TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.

Richard S Finn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.